Cancer Stem Cell News Volume 9.47 | Dec 16 2020

2020-12-16 | CSCN 9.47

Cancer Stem Cell News by STEMCELL Technologies
Vol. 9.47 – 16 December, 2020

Fat1 Deletion Promotes Hybrid EMT State, Tumor Stemness and Metastasis

Using mouse models of skin squamous cell carcinoma and lung tumors, investigators found that deletion of Fat1 accelerated tumor initiation and malignant progression and promoted a hybrid epithelial-to-mesenchymal transition (EMT) phenotype.


Free E-Book: Genome Editing Applications for Disease Modeling and Cell Therapy.
PUBLICATIONSRanked by the impact factor of the journal

MYC-Induced Human Acute Myeloid Leukemia Requires a Continuing IL-3/GM-CSF Costimulus

Scientists examined the combined and separate effects of an oncogene and exposure to interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and stem cell factor on the experimental genesis of a human acute myeloid leukemia in xenografted immunodeficient mice.


Marrow Niche ATP Levels Determine Leukemia-Initiating Cell Activity via P2X7 in Leukemic Models

The authors showed that ATP levels were markedly increased in the bone marrow niches of mice with acute myeloid leukemia, and leukemia-initiating cells preferred to localizing to the endosteal niche with relatively high ATP levels, as indicated by a sensitive ATP indicator.
[Journal of Clinical Investigation]

AbstractFull Article
Graphical Abstract

HIF1A Signaling Selectively Supports Proliferation of Breast Cancer in the Brain

Scientists found that cultured circulating tumor cells, derived from blood samples of women with advanced breast cancer and directly inoculated into the mouse frontal lobe, exhibited striking differences in proliferative potential in the brain.
[Nature Communications]

Full Article

Cell Network Integration in Glioma Represents a Stemness Feature

Glioblastoma cells that are part of the tumor microtube-connected tumor network showed activated neurodevelopmental and glioma progression gene expression pathways. Importantly, many of them revealed profiles indicative of increased cellular stemness, including high expression of nestin.


FZD5 Contributes to TNBC Proliferation, DNA Damage Repair and Stemness

Loss and gain of function studies revealed that FZD5 contributed to triple negative breast cancer cell G1/S transition, DNA replication, DNA damage repair, survival, and stemness. Mechanistically, transcription factor FOXM1, which promoted BRCA1 and BIRC5 transcription, acted as a downstream effecter of FZD5 signaling.
[Cell Death & Disease]

Full Article

Suppression of Poised Oncogenes by ZMYND8 Promotes Chemo-Sensitization

Researchers demonstrated that zinc-finger MYND type-8 (ZMYND8), a putative chromatin reader, suppressed stemness, drug resistance, and tumor-promoting genes, which are hallmarks of cancer.
[Cell Death & Disease]

Full Article

of a miRNA-Controlled Dual-Sensing System and Its Application for Targeting miR-21 Signaling in Tumorigenesis

Systemic application of miRDRELs to natural oncomiR targets, knockdown of key microprocessors, and physiological triggering of oncomiRs demonstrated that a lentivirus-based system was an effective tool for monitoring cellular oncomiR action.
[Experimental and Molecular Medicine]

Full Article

Combined PI3Kα-mTOR Targeting of Glioma Stem Cells

The authors utilized glioblastoma neurospheres that display glioblastoma stem cells characteristics and found activation of the PI3K/AKT pathway in sphere-forming cells. The PI3Kα selective inhibitor alpelisib blocked PI3K/AKT activation and inhibited spheroid growth, suggesting an essential role for the PI3Kα catalytic isoform.
[Scientific Reports]

Full Article

of CDK11B-Mediated SPDEF Ubiquitination and SPDEF-Mediated MicroRNA-448 Activation in the Oncogenicity and Self-Renewal of Hepatocellular Carcinoma Stem Cells

Investigators characterized the aberrant upregulation of CDK11B and downregulation SAM pointed domain-containing ETS transcription factor (SPDEF) in hepatocellular carcinoma tissues and cells.
[Cancer Gene Therapy]


Scientific resources to support your cancer research. Learn More!

Targeting Notch in Oncology: The Path Forward

Notch signaling is involved in many aspects of cancer biology, including angiogenesis, tumor immunity and the maintenance of cancer stem-like cells.
[Nature Reviews Drug Discovery]


First Patient Enrolled in Novocure® Global Phase III TRIDENT Trial of Optune® Concurrent with Radiation Therapy in Newly Diagnosed Glioblastoma

Novocure announced that the first patient has been enrolled in its global Phase III TRIDENT trial, a randomized study in newly diagnosed glioblastoma testing the potential survival benefit of initiating Optune® concurrent with radiation therapy.

Press Release


ISSCR: Vision 2030 A Forecast for the Field

January 7 – 8, 2021

> See All Events


Assistant – Melanoma Medical Oncology

University of Texas MD Anderson Cancer Center – Houston, Texas, United States

Postdoctoral Fellow – Breast Cancer Immuno-Oncology Research

Salk Institute of Biological Studies – La Jolla, California, United States

Faculty Position – Skin Cancer

Columbia University Medical Center – New York, New York, United States

Investigator – Replication Stress and Chromatin Alterations

NIH National Cancer Institute – Bethesda, Maryland, United States

Dean and Faculty Positions – Brain Cancer Biology

Peking University Shenzhen Graduate School – Shenzhen, China

> See All Jobs

Submit an article, publication, job or event
Brought to you by
stemcell-logo-for newsletter-2
Science News Cancer Stem Cell News
Archives Contact Us
Cancer Stem Cell News Twitter